Evidence map›Paper›PMID 25763593›Full record

ArticlePloS one2015

Arachidonic and linoleic acid derivatives impact oocyte ICSI fertilization--a prospective analysis of follicular fluid and a matched oocyte in a 'one follicle--one retrieved oocyte--one resulting embryo' investigational setting.

Przemysław Ciepiela, Tomasz Bączkowski, Arleta Drozd, Anna Kazienko, Ewa Stachowska, Rafał Kurzawa

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Ovarian aging: energy metabolism of oocytes.Journal of ovarian research · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Przemysław CiepielaDepartment of Reproductive Medicine and Gynecology, Pomeranian Medical University, Szczecin-Police, Zachodniopomorskie, Poland.
Tomasz BączkowskiDepartment of Reproductive Medicine and Gynecology, Pomeranian Medical University, Szczecin-Police, Zachodniopomorskie, Poland; VitroLive Fertility Clinic, Szczecin, Zachodniopomorskie, Poland.
Arleta DrozdDepartment of Biochemistry and Human Nutrition, Pomeranian Medical University, Szczecin, Zachodniopomorskie, Poland.
Anna KazienkoDepartment of Reproductive Medicine and Gynecology, Pomeranian Medical University, Szczecin-Police, Zachodniopomorskie, Poland.
Ewa StachowskaDepartment of Biochemistry and Human Nutrition, Pomeranian Medical University, Szczecin, Zachodniopomorskie, Poland.
Rafał KurzawaDepartment of Reproductive Medicine and Gynecology, Pomeranian Medical University, Szczecin-Police, Zachodniopomorskie, Poland; VitroLive Fertility Clinic, Szczecin, Zachodniopomorskie, Poland.
Pomeranian Medical University · PLZachodniopomorskie Centrum Onkologii · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate human oocyte ability to undergo fertilization and subsequent preimplantation embryonic development in relation to a wide panel of follicular fluid (FF) arachidonic acid derivatives (AAD) and linoleic acid derivatives (LAD) of prospectively selected patients undergoing intracytoplasmic sperm injection (ICSI). METHODOLOGY: Study was designed as a two center (a university clinic and a private clinic) prospective study. 54 women of 181 consecutive couples undergoing ICSI were prospectively found to be eligible for analysis. 'One follicle - one retrieved oocyte - one resulting embryo' approach was used. Each individual follicle was aspirated independently and matched to an oocyte growing in this particular follicular milieu. FF samples were assessed for AAD and LAD by high-performance liquid chromatography; additionally, activity of secretory phospholipase A (sPLA2) was determined by enzyme-linked immunosorbent assay. PRINCIPAL

findingsIncreased activity of sPLA2 and significantly higher AAD and LAD levels were found in FF of oocytes that did not show two pronuclei or underwent degeneration after ICSI in comparison to oocytes with the appearance of two pronuclei. Receiver operating characteristics curve analysis identified acids with the highest sensitivity and specificity: 5oxo-hydroxyeicosatetraenoic, 16-hydroxyeicosatetraenoic, 9-hydroxyoctadecadieneoic and 12-hydroxyeicosatetraenoic. No significant differences between AAD and LAD related to embryo quality were found. CONCLUSIONS/SIGNIFICANCE: Our study demonstrates for the first time that elevated concentrations of AAD and LAD in FF at the time of oocyte retrieval significantly decrease the ability of oocytes to form pronuclei after ICSI. This may serve as a new tool for non-invasive assessment of oocyte developmental capacity. However, levels of AAD and LAD are not associated with subsequent embryo quality or pregnancy rate, and therefore more studies are needed to determine their usefulness in human IVF procedure.

Indexed as

Embryonic DevelopmentArachidonic AcidChromatography, LiquidFemaleFollicular FluidHumansLinoleic AcidOocyte RetrievalPhospholipases A2, SecretoryPregnancyPregnancy RateProspective StudiesROC CurveSperm Injections, IntracytoplasmicArachidonic AcidLinoleic AcidPhospholipases A2, Secretory

Identifiers

PMID25763593
PMCPMC4357448
OpenAlexW1981211303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.